Rejuvenation Technologies Raises $10.6M Seed Financing Led By Khosla Ventures To Develop Mrna Therapeutics To Reverse Aging
Amount Raised
$10.6 Million
Round Type
Seed
Mountain ViewBiotechnologyHealth CareTherapeuticsInvestors
Description
Rejuvenation Technologies, a biotechnology company developing mRNA-based therapeutics to address mechanisms of aging, today announced a $10.6M seed financing round led by Khosla Ventures. Shanda Ventures, Asymmetry Ventures, Merchant Adventures, Longevity Tech Fund, and Y Combinator also participated in the round. The company has also raised $4.6M in grant funding, bringing the total amount raised to $15.2M.
Who to call at Rejuvenation Technologies, and when
A new round usually means Rejuvenation Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rejuvenation Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rejuvenation Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rejuvenation Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rejuvenation Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rejuvenation Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.